非传染性疾病的药物坚持量表:对设计缺陷,构造和验证过程的范围审查
Maria Jose1, Priyanka Rajmohan2, T S Sulfath2
1Department of Pharmacology, Jubilee Mission Medical College & Research Institute, Thrissur, India.
PloS one
|May 14, 2025
概括
现有的非传染性疾病 (NCD) 药物坚持量表往往忽视了成本和系统障碍等关键因素. 未来的工具需要更全面,更具背景意识,以改善患者护理和结果.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 患者坚持性研究
- 非传染性疾病管理
背景情况:
- 非传染性疾病 (NCD) 受生活方式,饮食,心理社会因素,年龄和遗传学的影响.
- 药物不服药是一个重大的全球问题,恶化了疾病的进展和患者的结果.
研究的目的:
- 对非传染性疾病的药物坚持度表进行范围审查.
- 分析这些尺度的发展,心理测量属性和评估领域.
- 识别当前粘附度测量工具中的局限性和缺口.
主要方法:
- 该审查遵循了乔安娜·布里格斯研究所 (JBI) 的方法框架.
- 搜索包括电子数据库,参考列表和从1950年到2024年的灰色文献.
- 两个独立审稿人选文章,第三个解决冲突;JBI尺度被用于批判性评估.
主要成果:
- 审查了140篇文章,确定了57个不同的药物坚持量表.
- 使用定性,文献综述或混合方法开发了尺度,重点关注行为方面.
- 关键的局限性包括忽视与成本相关的不合规性,自我有效性,系统性障碍,以及在不同人群中缺乏验证.
结论:
- 目前对非传染性疾病的药物坚持度表存在重大差距,特别是在解决社会经济和文化因素方面.
- 需要更全面,更适合环境的尺度来整合这些维度.
- 改进的坚持测量可以提高以患者为中心的护理,告知政策,并改善健康结果.
相关概念视频
Drug Therapy
32
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
32
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Structure-Activity Relationships and Drug Design
461
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461
Data Validation
4.8K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
Nursing assessment guides are generally based on holistic models rather than medical...
4.8K
Pharmacovigilance
753
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
753
Assessment of the Cardiovascular System I: Subjective Data
244
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
244


